SoutheastHEALTHis set to begin implementation of the COVID-19 Vaccination Program established by the Missouri Department of Health, following final Emergency Use Authorization (EUA) by the Food and Drug Administration last week. Vaccinations will begin this week for SoutheastHEALTH employees. SoutheastHEALTH expects to initially receive 2,925 doses of the Pfizer brand vaccine, which is a two-dose series given 21 days apart. Southeast Hospital also has the ultra-cold storage units required for the Pfizer vaccine. Its lab has, and continues, to play a major role in the COVID-19 testing process. SoutheastHEALTH’s lab was the first in the region to obtain advanced testing capabilities for COVID-19, due to its expansive outreach lab footprint that currently serves over 680 clients in 10 states across the southeast region of the U.S. As vaccine availability expands in the following weeks, Janzow said SoutheastHEALTH will strategically target vaccination efforts with a phased approach as set forth by the Missouri Department of Health and Senior Services Bureau of Immunizations. It is as follows:
Phase one – healthcare workers, essential workers, high risk populations. Phase two – Phase one populations, all Missouri residents as availability of vaccine increases. Phase three – All Missouri residents. SoutheastHEALTH will make more information available on its website as this statewide process continues. For information on vaccine availability and updates, go to: SEhealth.org/COVID.